SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
土豪的傲菡
Lv2
150 积分
2022-11-15 加入
最近求助
最近应助
互助留言
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer
4天前
已完结
Gemcitabine as single-agent therapy in the management of advanced breast cancer
6天前
已关闭
Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial
1个月前
已完结
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial
1个月前
已完结
Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study
1个月前
已完结
Subcutaneous Mosunetuzumab in Relapsed or Refractory B-Cell Lymphoma: Promising Safety and Encouraging Efficacy in Dose Escalation Cohorts
1个月前
已关闭
Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial
2个月前
已完结
Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial
2个月前
已完结
subcutaneous Tocilizumab vs Placebo in Combination With Disease Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis
3个月前
已完结
Mechanism ‐ Based Approach Using a Biomarker Response to Evaluate Tocilizumab Subcutaneous Injection in Patients With Rheumatoid Arthritis With an Inadequate Response to Synthetic DMARDs (MATSURI Study)
3个月前
已完结
没有进行任何应助
点赞,帮大忙了,么么哒
4天前
感谢,点赞,帮大忙了
1个月前
感谢,点赞,帮大忙了,么么哒
1个月前
速度真快,点赞,帮大忙了,么么哒
1个月前
自己搜到了【积分已退回】
1个月前
感谢,点赞,帮大忙了,么么哒
2个月前
点赞,速度真快,帮大忙了,么么哒,感谢
2个月前
点赞,速度真快
3个月前
速度真快,帮大忙了,么么哒,点赞
3个月前
已经找到【积分已退回】
3个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论